Antidiabetic Drugs in NAFLD: The Accomplishment of Two Goals at Once?

Tacelli, M; Celsa, C; Magro, B; Giannetti, A; Pennisi, G; Spatola, F; Petta, S

Petta, S (reprint author), Univ Palermo, DiBiMIS, Sez Gastroenterol & Epatol, I-90127 Palermo, Italy.

PHARMACEUTICALS, 2018; 11 (4):

Abstract

Non-Alcoholic Fatty Liver Disease (NAFLD) is the most common cause of chronic liver disease in Western countries, accounting for 20-30% of general pop......

Full Text Link